"Drugmakers and insurers are aiming to take advantage of lawmakers’ worries about affordability to convince them it’s the hospitals they should regulate, and not them, if they want to bring down Americans’ bills. Some of the changes the drugmakers and insurers are pursuing would pad their own profits."

politico.com/news/2026/05/17/h…

#healthcare #hospitals #PhRMA #PrescriptionDrugs #insurance #insurers #medicaid #medicare #CostsOfCare #DrugPrices

"India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?

Not this decade, experts say.

Thanks largely to loopholes in the U.S. patent system, Americans aren’t expected to get generic forms of semaglutide, the drug in Novo Nordisk’s Ozempic and Wegovy, until at least the end of 2031."

nbcnews.com/health/health-news…

#healthcare #PrescriptionDrugs #GenericDrugs #PatentLaw #semaglutide #DrugPrices #CostsOfCare